Capsule Endoscopy Market is expected to reach US$ 757.51 million by 2028

The global capsule endoscopy market is expected to reach US$ 757.51 million by 2028; registering at a CAGR of 8.4% from 2022 to 2028, according to a new research study conducted by The Insight partners

Product Segment to Lead Capsule Endoscopy Market During 2022–2028

The report highlights the key factors driving the market and prominent players with their developments.

The rising prevalence of gastrointestinal disorders (GIDs) is increasing the demand for capsule endoscopes. Capsule endoscopy is useful in diagnosing GI bleeding in small bowel disease, celiac disease, Crohn's disease, small-bowel tumors, and non-steroidal anti-inflammatory drug-induced enteropathy in the small and large bowel. It is a more effective tool for examining the small intestine than conventional endoscopes. Capsule endoscopy has evolved where different capsules are available to examine different parts of the GI tract. “PillCam SB3”, “Olympus Endocapsule”, and “Micro Cam” are a few examples of capsule endoscopes that are highly utilized for the monitoring of the small intestine. Further, capsule endoscopy is used for diagnosing and monitoring diseases throughout the entire GI tract. Therefore, with the rising prevalence of GI disorders, the demand for capsule endoscopes is high, fueling the overall market growth during the forecast period.

Capsule Endoscopy Market, by Region, 2022 (%)

Source: The Insight Partners Analysis

Further, the demand for wireless capsule endoscopy is supporting the overall capsule endoscopy market growth during the forecast period. Wireless capsule endoscopy is less traumatic for the patients and does not require sedation or close monitoring by the hospital staff during the procedure compared to invasive enteroscopy or other endoscopic techniques. Also, the wireless capsule endoscopy standalone advantage is that it is the only technique to provide images of the inside of the small intestine, as other endoscopic equipment can only reach the large intestine and upper digestive tract. Additionally, wireless capsule endoscopy comprises low-power transmission that has been designed to achieve the purpose of low-power consumption and high-quality medical imaging. Therefore, clinical benefits offered to patients through wireless capsule endoscopy influences the overall market growth during the forecast period.

The utility of home-based capsule endoscopy is expected to offer lucrative opportunities for the capsule endoscopy market growth in the coming years. According to the Association for the Advancement of Medical Instrumentation 2020 published article, Food & Drug Administration (FDA) announced approval for an at-home endoscope (small bowel capsule) used amid the COVID-19 pandemic manufactured by Silicon Valley-based Capsovision. The device by CapsoCam Plus video capsule system is intended for the visualization of small bowel mucosa among adults and abnormalities related to the small bowel. Further, the company's advanced capsule technology delivers high-quality diagnostic imaging without creating a risk of in-person exposure to COVID-19. For example, for the images, a patient swallows the capsule and uses a stool-based retrieval system for capturing the capsule, and the images are reviewed by physicians using cloud-based software. Such home-based capsule endoscopy will offer lucrative opportunities for the overall market growth in the coming years.

RF Co., Ltd.; JINSHAN Science & Technology; SHANGXIAN MINIMAL INVASIVE INC; CapsoVision; Check-Cap.; INTROMEDIC; Medtronic; Olympus Corporation; and Anhan Technology (Wuhan) Co., Ltd. are among the leading companies operating in the capsule endoscope market.

The report segments the capsule endoscope market as follows:

Based on product, the capsule endoscopy market is bifurcated into endoscopy capsule and components. The endoscopy capsule segment held a larger share of the market in 2022. Based on formulation, the capsule endoscopy market is bifurcated into tablets and capsules. The capsule segment held a larger share of the market in 2022. Based on application, the capsule endoscopy market is segmented into obscure gastrointestinal bleeding (OGIB), Crohn's disease, small bowel diseases, and other diseases. Based on end user, the market is segmented into hospitals, clinics, research centers, and other end users. The hospitals held the largest share of the market in 2022. Based on geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com